Skip to main content

Bone Biologics Corp

BBLG
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001419554

No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $35.7K in total; no superinvestor holds it.

Key figures

Market capCalculated value looks implausible
–
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, 0 vs. previous quarter
3
13F valueReported value at the end of Q2 2026
$35.7K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$3.11M
No comparable prior period
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
17.6K
Shares sold short
Change
−5.14K
−22.6% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding BBLG, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding BBLG at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Bone Biologics Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2023 (view filing)Sep 131 dayWalsh Deina HChief Financial OfficerPPurchase+8.00K$0.64+$5.12K+114.3%15.0K after
Sep 12, 2023 (view filing)Sep 111 dayFrelick JeffChief Executive OfficerPPurchase+9.50K$0.69+$6.55K+123.3%17.2K after
Sep 7, 2023 (view filing)Sep 61 dayWalsh Deina HChief Financial OfficerPPurchase+7.00K$0.7096+$4.97KNew position7.00K after2 lots
Sep 5, 2023 (view filing)Aug 315 daysFrelick JeffChief Executive OfficerPPurchase+7.60K$0.66+$5.02K+7,307.7%7.70K after

Top 10 13F holders, Q2 2026

See all 3 holders

The largest institutional positions in Bone Biologics Corp at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding BBLG in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC23,879$32.7K0.00%+23,879New
Tower Research Capital LLC (TRC)1,953$2.68K0.00%−2,173−52.7%Reduced
SBI Securities Co., Ltd.230$3150.00%00.0%Unchanged

Holders of 5% or more of BBLG

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bone Biologics Corp.

Largest holders of BBLG from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Intracoastal Capital, LLC13G/A9.99%305.9K shares0.00 ppfrom 9.99%Nov 27, 20236 filingsNov 10, 2026SEC